Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Disposition to Issuer of 91,204 TBPH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Theravance Biopharma, Inc. (TBPH) | Disposition to Issuer | 91,204 | n/a |
| Jun 17, 2026 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 6,009 | n/a |
| Jun 12, 2026 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 1,371 | n/a |
| Sep 25, 2025 | Praxis Precision Medicines, Inc. (PRAX) | Exercise/Conversion | 1,932 | $27.7K |
| Jun 27, 2025 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 10,520 | n/a |
| May 21, 2025 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 10,649 | n/a |
| Jun 6, 2024 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 8,566 | n/a |
| May 10, 2024 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 10,537 | n/a |
| Apr 5, 2024 | Kinnate Biopharma Inc. (KNTE) | Disposition to Issuer | 121,503 | n/a |
| Mar 18, 2024 | PRECIGEN, INC. (PGEN) | Grant/Award | 39,510 | $56.5K |